Status:
COMPLETED
Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD
Lead Sponsor:
Pfizer
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
Up to 80 years
Phase:
PHASE4
Brief Summary
To investigate whether a long-term strategy to lower LDL cholesterol with atorvastatin as much as possible will improve prognosis in CHD patients compared with a strategy reflecting current best clini...
Eligibility Criteria
Inclusion
- Previous myocardial infarction
Exclusion
- Women who are breast feeding or are pregnant
Key Trial Info
Start Date :
February 1 1999
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
8600 Patients enrolled
Trial Details
Trial ID
NCT00159835
Start Date
February 1 1999
End Date
March 1 2005
Last Update
April 22 2015
Active Locations (194)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Arhus C, Denmark, DK-8000
2
Pfizer Investigational Site
Copenhagen, Denmark, 2100
3
Pfizer Investigational Site
Elsinore, Denmark, 3000
4
Pfizer Investigational Site
Esbjerg, Denmark, 6700